drugset / Trial / NCT00313820

Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain

NCT00313820

Phase 4 Completed 220 enrolled Viatris Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

Efficacy and Safety of flexibly dosed pregabalin compared to placebo among subjects with central post stroke pain (CPSP)

Timeline

Start
2006-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg
Comparator Pregabalin Small molecule 600 mg